A real-world stepped wedge cluster randomized trial of practice facilitation to improve cardiovascular care by Clare Liddy et al.
RESEARCH Open Access
A real-world stepped wedge cluster
randomized trial of practice facilitation to
improve cardiovascular care
Clare Liddy1,2,9*, William Hogg1,2, Jatinderpreet Singh1,2, Monica Taljaard3,4, Grant Russell1,5,
Catherine Deri Armstrong6, Ayub Akbari7, Simone Dahrouge1,2 and Jeremy M. Grimshaw3,8
Abstract
Background: Practice facilitation has been associated with meaningful improvements in disease prevention and
quality of patient care. Using practice facilitation, the Improved Delivery of Cardiovascular Care (IDOCC) project
aimed to improve the delivery of evidence-based cardiovascular care in primary care practices across a large health
region. Our goal was to evaluate IDOCC’s impact on adherence to processes of care delivery.
Methods: A pragmatic stepped wedge cluster randomized trial recruiting primary care providers in practices located
in Eastern Ontario, Canada (ClinicalTrials.gov: NCT00574808). Participants were randomly assigned by region to one
of three steps. Practice facilitators were intended to visit practices every 3–4 (year 1—intensive) or 6–12 weeks
(year 2—sustainability) to support changes in practice behavior. The primary outcome was mean adherence to
indicators of evidence-based care measured at the patient level. Adherence was assessed by chart review of a
randomly selected cohort of 66 patients per practice in each pre-intervention year, as well as in year 1 and year 2
post-intervention.
Results: Eighty-four practices (182 physicians) participated. On average, facilitators had 6.6 (min: 2, max: 11) face-
to-face visits with practices in year 1 and 2.5 (min: 0 max: 10) visits in year 2. We collected chart data from 5292
patients. After adjustment for patient and provider characteristics, there was a 1.9 % (95 % confidence interval
(CI): −2.9 to −0.9 %) and 4.2 % (95 % CI: −5.7 to −2.6 %) absolute decrease in mean adherence from baseline to
intensive and sustainability years, respectively.
Conclusions: IDOCC did not improve adherence to best-practice guidelines. Our results showed a small
statistically significant decrease in mean adherence of questionable clinical significance. Potential reasons for this
result include implementation challenges, competing priorities in practices, a broad focus on multiple chronic
disease indicators, and use of an overall index of adherence. These results contrast with findings from previously
reported facilitation trials and highlight the complexities and challenges of translating research findings into
clinical practice.
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Introduction
Practice facilitation is an approach to implementing
evidence-based best practices in primary care [1]. It
involves bringing an external healthcare professional
(often a trained nurse with management experience) into
a practice, in order to help primary care providers
address the challenges associated with implementing
evidence-based guidelines. Practice facilitators (also
known as outreach facilitators, practice enhancement
assistants, and practice coaches) are trained experts in
initiating change in practices. They work with practices
to identify areas for improvement, set care improvement
goals, and provide tools and approaches to reach these
goals. Facilitation has been found to lead to improve-
ments in prevention, diabetes care, smoking cessation,
and cancer care [2–4]. A recent meta-analysis demon-
strated that primary care providers are more likely to
adopt evidence-based guidelines when supported by a
facilitator [5]. Furthermore, a cost consequence analysis
of a facilitation study that focused on improving pre-
ventive care in primary care practices demonstrated a
40 % return on intervention investment [6].
Facilitation programs are being broadly implemented by
practice-based research networks, health departments,
professional associations, and health plans. As such, on-
going evaluation is needed to determine the effectiveness
of practice facilitation in real-world settings.
The adoption, optimal intensity, and duration of
practice facilitation remain uncertain, as does the ef-
fectiveness beyond single-disease-focused facilitation
programs [1, 2, 5, 7–9].
We initiated the Improved Delivery of Cardiovascular
Care (IDOCC) through an outreach facilitation project in
2007 to improve adherence to guidelines for the secondary
prevention of heart disease, stroke, peripheral vascular dis-
ease, renal disease, and diabetes in primary care practices
in a health region [10]. We hypothesized that facilitation
would enable practices to improve overall adherence to
cardiovascular care guidelines. This paper reports on our
primary outcome of adherence to guidelines as measured
by mean adherence to care delivery in the practice, based
on patient-level data.
Methods
The IDOCC study protocol has been published elsewhere
[10], so here, we provide a brief overview of the methods
as per CONSORT [11].
Setting and participants
We conducted the study in a large health region in Eastern
Ontario, Canada (16,000 km2), including Ottawa and the
surrounding rural communities. It is a culturally diverse
region of 1.2 million individuals who have chronic disease
burdens and patient health outcomes comparable to
Ontario and the rest of Canada [12].
Practices were eligible to participate if they provided
general primary care services and had been in operation
for at least 2 years prior to the initiation of the interven-
tion. We enlisted practices if at least one physician from
that practice consented to participate. Physicians received
no monetary compensation for participating but were
eligible for continuing professional development credits
with the College of Family Physicians of Canada.
Design
We used a stepped wedge cluster randomized trial de-
sign (see Fig. 1) in which the intervention was sequen-
tially rolled out to participating primary care practices
assigned by region in three steps. Each step provides
data for both control and intervention periods, and data
analysis proceeds by comparing time points across steps
in control versus intervention periods.
We chose the stepped wedge design to (1) minimize
the practical, logistical, and financial constraints associ-
ated with large-scale project implementation, (2) control
for the effect of time, and (3) ensure that all practices in
the project were eventually offered the intervention [13].
The Ottawa Hospital Research Ethics Board approved
this trial (2007292-01H).
Randomization
We divided the health region systematically into nine
geographic divisions using geographic information sys-
tem mapping technology [14], stratifying the divisions by
their location within the region (i.e., west, central, and
east). We randomly assigned each of the three divisions
per stratum (i.e., west, central, or east) to one of three
study steps using computer-generated random numbers
provided by an independent statistician. Each step com-
prised three divisions, with each step having a division
from the east, central, and west part of the region. As
such, each division per stratum had the same probability
of beginning the program at any given step.
We developed a list, updated prior to recruitment at
each step, of the contact information of all physicians
practicing in the geographic regions of interest using a
variety of physician listings such as The College of Physi-
cians and Surgeons of Ontario website [15], the public
telephone directory, a provincial directory of group prac-
tices, and through direct contact with the practices. We
used a modified Dillman approach to recruit practices.
This involved sending reminders and repeat mailings from
the study team [16]. Recruitment continued in each step
until we reached the desired sample. We obtained consent
from all participating physicians.
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Intervention
The intervention consisted of regular meetings with a
facilitator over the study period. Practice facilitators
intended to visit with practices 13 times (i.e., one visit
every 4 weeks) in year 1 (intensive phase) and then 4–6
times (i.e., one visit every 8–12 weeks) in year 2 (sustain-
ability phase). Starting with audit and feedback, consen-
sus building and goal setting, the facilitators supported
practices in changing their behavior through the incorp-
oration of the following chronic care model elements:
(1) integrated evidence-based care guideline and other
decision support tools, (2) enhanced community link-
ages, (3) self-management support, and (4) delivery sys-
tem redesign such as introducing a practice population
approach, recall systems, and disease-specific registries.
Facilitators encouraged practices to implement small but
continuous changes through the plan-do-study-act cycle,
which is a common quality improvement tool [17]. Full
details of the intervention have been published previ-
ously [10] and are available in Additional file 1.
Outcome
The primary outcome for the trial was a patient-level
score intended to reflect adherence to recommended
guidelines for cardiovascular disease processes of care.
The score represented the percentage of recommended
process of care indicators for which the patient was
eligible that were performed on the patient over a 1-year
period. The indicators were (1) two blood pressure mea-
sures, (2) lipid profile, (3) waistline measure, (4) smoking
status, (5) glycemic levels (two hemoglobin A1c measures
for patients with diabetes or one fasting blood glucose for
high-risk patients without diabetes), (6) kidney function
(albumin-to-creatinine ratio or estimated glomerular
filtration rate), (7) prescription of all eligible medications,
and (8) referral to a smoking cessation program. For each
step, we measured mean adherence for baseline time
points and for the intensive (year 1) and sustainability
(year 2) phases.
Data collection
The unit of intervention was the practice, but the unit of
analysis and causal inference was the patient. Causal in-
ference refers to the fact that although the intervention
is aimed at producing a system-level change in the prac-
tice, the assessment of this change will occur at the pa-
tient level through the review of medical charts from the
practice. For each practice, we randomly selected 66
charts of patients who were over age 40 and (1) had car-
diovascular disease including coronary artery disease,
cerebrovascular disease (stroke and/or transient ische-
mic attack), or peripheral vascular disease; (2) had dia-
betes or chronic kidney disease; or (3) were at high risk
of developing cardiovascular disease as defined by age
(males ≥45, females ≥55), smoking status, hypertension,
weight, or dyslipidemia. The same patients were
followed over time to assess outcomes.
We collected data for each time block in the stepped
wedge design as highlighted in Fig. 1. We used the base-
line data collection over 1 year from each practice for
the audit and feedback stage of the facilitator interven-










































Fig. 1 IDOCC stepped wedge study design. Shaded cells represent intervention periods. Blank cells represent control periods
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(1 year of baseline data, intensive year, and sustainability
year), step II practices provided 4 years of data (2 years
of baseline data, intensive year, and sustainability year),
and step III practices provided 5 years of data (3 years of
baseline data, intensive year, and sustainability year).
Six trained nurses completed the chart abstraction. A
four-part quality implementation and monitoring
process was used to ensure consistent levels of data
quality across chart abstractors. Full details of our chart
abstraction methods are described elsewhere [18].
We collected practice-level data through practice sur-
veys and by linking family physicians’ medical ID to their
demographic and practice model information contained
in the Institute for Clinical Evaluative Sciences’ Corpor-
ate Provider Database, which reflects characteristics as
of March 31, 2008 [17, 19].
The chart abstractors, facilitators, and practices were
blinded to the full details of which data were being
collected for the primary outcome analysis, and chart
abstractors were additionally blinded as to whether the
practice they were auditing was in the control or inter-
vention phase.
Sample size calculation
There are as yet no published sample size formulae for a
stepped wedge trial with a cohort design. Using the
sample size calculation formula for a two-arm parallel
design, we determined that 21 practices in each of the
intervention and control arms with an average of 66
patients per practice (the anticipated average number of
eligible patients per practice based on pilot data) would
detect an 8 % absolute mean difference (deemed clinic-
ally relevant) in the mean adherence score using a two-
sided test at the 5 % level of significance with 90 %
power. This difference was deemed clinically relevant after
conducting a series of simulations followed by discussions
with a panel of family physicians and cardiologists. Our
calculations assumed an intra-cluster correlation coeffi-
cient of 0.18 and a common standard deviation of 18 %
calculated using IDOCC pilot data on nearly 500 patients
across seven practices. Our target sample size was 30
practices in each step of the stepped wedge design to
account for 20 % potential attrition. Since the stepped
wedge design includes repeated observation periods per
practice and is therefore more powerful than the simple
parallel design, this sample size estimate was considered
to be conservative [20].
Data analysis
We generated descriptive statistics summarizing practice
and patient characteristics for the entire sample and for
each step separately. We used general linear mixed-effect
Table 1 Breakdown of practice-, provider-, and patient-level characteristics at baseline by step
Characteristic Step I Step II Step III Overall
Practice level
Number of practices (n) 27 30 27 84
Primary care model (n, %)
Fee for service 22 (81.5 %) 12 (40.0 %) 11 (40.7 %) 45 (53.5 %)
Capitation—non-interdisciplinary 1 (3.7 %) 8 (26.7 %) 11 (40.7 %) 20 (23.8 %)
Capitation—interdisciplinary 0 (0.0 %) 4 (13.3 %) 3 (11.1 %) 7 (8.3 %)
Community health centers 4 (14.8 %) 6 (20.0 %) 2 (7.4 %) 12 (14.3 %)
Rural practices (n, %) 4 (14.8 %) 4 (13.3 %) 7 (25.9 %) 15 (17.9 %)
Baseline adherence score (mean, SD) 0.62 (0.20) 0.65 (0.22) 0.64 (0.22) 0.64 (0.22)
Provider level
Number of providers (n) 57 78 47 182
Female (n, %) 34 (59.7 %) 51 (65.4 %) 27 (57.5 %) 112 (61.5 %)
Years since graduation from 2010 (SD) 27 (10) 23 (7) 25 (10) 25 (9)
Patient level
Number of patients (n) 1667 1891 1734 5292
Age (mean, SD) 68 (13) 66 (12) 67 (12) 66 (12)
Female (n, %) 852 (51.1 %) 1003 (53.0 %) 851 (49.1 %) 2706 (51.1 %)
Number of cardiovascular-related conditionsa (mean, SD) 1.18 (0.91) 1.17 (0.95) 1.26 (0.97) 1.20 (0.95)
Number of cardiovascular risk factorsb (mean, SD) 2.67 (0.81) 2.82 (0.68) 2.79 (0.74) 2.76 (0.75)
Rural residents (n, %) 436 (26.2 %) 440 (23.3 %) 774 (44.6 %) 1650 (31.2 %)
aCardiovascular-related diseases examined: stroke, coronary artery disease, peripheral vascular disease, diabetes, chronic kidney disease
bRisk factors assessed were age, hypertension, dyslipidemia, and smoking
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regression modeling as described by Hussey and Hughes
to assess the impact of the IDOCC program on the pri-
mary outcome [21]. To assess the normality of the distri-
bution of the primary outcome, we used visual inspection
of histograms.
The model included fixed effects for time, treatment
phase, and region and a random effect for the practice.
Regions were treated as fixed—rather than as rando-
m—effects as they could not be considered a sample
from some population but reflected a systematic division
of Eastern Ontario. In addition, a compound symmetric
covariance structure was specified to account for the
correlation in repeated measures on the same patient



















































Fig. 3 Estimated effect of the IDOCC intervention presented as adjusted mean adherence score (%) averaged over all practices in control,
intensive, and sustainability conditions. The model assumes a single underlying secular trend across steps and estimates a shift in level as a result
of the intervention. Solid lines represent time intervals with observed data in that condition; dashed lines represent time intervals with no
observed data in that condition
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Table 2 Results from multivariable mixed-effect regression analyses of the effect of the IDOCC intervention
Parameter Model A Model B Model C
(Unadjusted) (Adjusted for patient factors) (Adjusted for patient/provider factors)
Estimatea P value 95 % CI Estimatea P value 95 % CI Estimatea P value 95 % CI
Intercept 61.4 <0.0001 56.7 to 66.1 39.2 <0.0001 32.6 to 45.9 44.97 <0.0001 34.8 to 55.1
Time
Year 1 Ref - - Ref - - Ref - -
Year 2 1.5 <0.0001 0.8 to 2.3 0.9 0.02 0.2 to 1.7 0.9 0.019 0.2 to 1.7
Year 3 4.2 <0.0001 3.2 to 5.3 3.0 <0.0001 1.9 to 4.0 3.0 <0.0001 1.9 to 4.0
Year 4 6.3 <0.0001 4.6 to 7.9 4.4 <0.0001 2.8 to 6.0 4.4 <0.0001 2.8 to 6.0
Year 5 7.3 <0.0001 5.1 to 9.5 4.9 <0.0001 0.027 to 0.071 4.9 <0.0001 2.7 to 7.1
Intervention phase
Baseline Ref - - Ref - - Ref - -
Intensive −2.1 <0.0001 −3.2 to −1.1 −1.9 0.0003 −2.9 to −0.9 −1.9 0.0003 −2.9 to −0.9
Sustainability −4.7 <0.0001 −6.2 to −3.2 −4.2 <0.0001 −5.7 to −2.6 −4.2 <0.0001 −5.7 to −2.6
Region
Region 1 Ref - - Ref - - 1.0 0.789 −6.6 to 8.7
Region 2 1.1 0.756 −5.9 to 8.1 1.4 0.695 −5.5 to 8.3 4.1 0.25 −2.9 to 11.0
Region 3 3.8 0.205 −2.1 to 9.7 3.5 0.24 −2.3 to 9.3 2.7 0.531 −5.7 to 11.0
Region 4 2.4 0.535 −5.3 to 10.2 2.3 0.545 −5.3 to 9.9 0.2 0.956 −6.7 to 7.1
Region 5 2.4 0.441 −3.6 to 8.3 0.8 0.780 −5.1 to 6.8 3.7 0.293 −3.2 to 10.6
Region 6 4.5 0.157 −1.7 to 10.7 3.7 0.231 −2.4 to 9.9 5.4 0.184 −2.6 13.4
Region 7 5.7 0.121 −1.5 to 13.0 5.7 0.116 −1.4 to 12.9 Ref - -
Region 8 −1.3 0.745 −9.0 to 6.4 −1.0 0.798 −8.6 to 6.6 4.8 0.189 −2.4 to 12.1
Region 9 2.3 0.454 −3.7 to 8.3 2.2 0.476 −3.9 to 8.1 2.1 0.576 −5.1 to 9.2
Patient level
Age 0.03 0.168 −0.01 to 0.06 0.03 0.14 −0.009 to 0.07
Sex 0.09 0.825 −0.7 to 0.9 0.07 0.872 −0.8 to 0.9
Income 0.39 0.004 0.1 to 0.7 0.4 0.0035 0.13 to 0.67
# of cardiovascxular-related diseasesb
0 (risk factors Only) Ref - - Ref - -
1 4.8 <0.0001 3.9 to 5.8 4.8 <0.0001 3.9 to 5.8
2 6.9 <0.0001 5.7 to 8.0 6.9 <0.0001 5.7 to 8.0
3 6.6 <0.0001 5.1 to 8.1 6.6 <0.0001 5.1 to 8.2












Table 2 Results from multivariable mixed-effect regression analyses of the effect of the IDOCC intervention (Continued)
5 11.0 0.001 4.3 to 17.6 11.0 0.0012 4.4 to 17.6
# of risk factors for cardiovascular diseasec
0 Ref - - Ref - -
1 6.5 0.0009 2.6 to 10.3 6.5 0.0009 2.6 to 10.3
2 12.7 <0.0001 9.0 to 16.4 12.7 <0.0001 8.9 to 16.4
3 17.1 <0.0001 13.4 to 20.9 17.1 <0.0001 13.4 to 20.9
4 4.7 0.017 0.8 to 8.5 4.6 0.019 0.8 to 8.5
Rural 0.0099 0.103 −0.2 to 2.2 0. 9 0.141 −0. 3 to 2.1
Provider level
Payment model
FFS Ref - -
Capitation 1.4 0.437 −2.1 to 4.9
Salary 9.0 0.710 −3.7 to 5.5
Female physician 1.7 0.320 −1.6 to 5.0
Years since graduation (as of 2010) −0.27 0.0015 −0.4 to −0.1
aNegative estimate indicates a decrease in adherence
bCardiovascular-related diseases examined: stroke, coronary artery disease, peripheral vascular disease, diabetes, chronic kidney disease












maximum likelihood. In the analysis, the treatment vari-
able was specified as a three-level categorical variable
(baseline, intensive, sustainability).
We conducted an unadjusted analysis (model A)
followed by two adjusted analyses: model B adjusted for
patient characteristics (age, sex, median neighborhood
income, number of cardiovascular-related diseases, num-
ber of cardiovascular-related risk factors, and rurality)
[22, 23], while model C included three practice-level
characteristics that have been shown to influence pri-
mary care practice adherence to guidelines (payment
model, percentage of participating physicians that were
female, and average number of years since graduation
(to 2010)) [24, 25]. We carried out pairwise comparisons
between mean adherence scores across the different
treatment years (baseline, intensive year, sustainability
year) at the 0.017 Bonferroni-corrected level to maintain
the familywise error rate at 5 %. We calculated adjusted
least square mean adherence scores in each phase by
setting continuous covariate values equal to their mean
values and using observed marginal distributions for cat-
egorical variables. Thus, least square mean differences
represent the estimated effect of the intervention on the
quality of care for an “average” patient in an “average”
practice. All analyses were conducted using SAS, Version
9.3, SAS Institute Inc.
Results
We approached all 533 primary care practices in the
Champlain region to participate in the IDOCC program.
Ninety-nine were ineligible to participate because the
practice was no longer in operation, the clinic was an
exclusive walk-in practice, or the physician running the
practice was planning to retire within the 2-year inter-
vention time frame. Of the 434 eligible practices, 93
practices (21 %) (194 physicians) agreed to participate.
Nine practices withdrew from the study prior to the
initiation of the facilitation intervention for various
reasons, including not having the office space to accom-
modate a chart abstractor and insufficient number of eli-
gible high-risk patient charts, leaving 84 participating
practices (182 physicians): 27, 30, and 27 in steps I, II,
and III, respectively. The withdrawal of ten practices
from the study resulted in a loss of only 12 physicians,
suggesting that only small or single physician practices
chose to withdraw. The first facilitation visit was on
April 14, 2008, and the final site visit was March 27,
2012. The trial concluded as scheduled at the end of the
intervention phase for step III. No practices withdrew
after the start of the intervention.
Baseline characteristics of participating practices, pro-
viders, and patients are presented in Table 1. The major-
ity of participating practices were fee-for-service (53.5 %)
and located in urban areas (82.1 %).
We collected baseline data from 5292 patient medical
charts, of which 627 (11.8 %) were lost at follow-up,
primarily due to patients dying or moving within the
study period. Chart abstraction data quality assessments
via re-abstractions demonstrated an overall inter-rater
reliability kappa value of 0.91 and a percent agreement
of 93.9 %.
No practices received the intended intensity of facilita-
tor visits. Only 32 practices had eight or more visits over
2 years. On average, facilitators had 6.6 (min: 2 max: 11)
face-to-face visits with practices in year 1 and 2.5 (min:
0 max: 10) visits in year 2. In addition to face-to-face
visits, facilitators communicated with practices an aver-
age of 1.7 times using phone or email in year 1 and 1.6
times in year 2.
Figure 2 presents the observed mean adherence scores
for each study step during the baseline, intensive, and
sustainability years. There is little change in the mean
adherence score pre- and post-intervention for all prac-
tices in all three steps. Additionally, the three baseline
time points for step III appear to show a (modest)
upward secular trend in mean adherence, highlighting
the importance of controlling for the time trend in the
subsequent regression analysis. Fig. 3 presents the esti-
mated effect of the IDOCC intervention presented as ad-
justed mean adherence score averaged over all practices
in control, intensive, and sustainability conditions.
Using data from all three steps, the unadjusted (model
A) least square mean differences showed an absolute
decrease from baseline of 2.1 % in the intensive phase
(95 % CI: −3.1 to −1.1 %) and a decrease of 4.7 % in the
sustainability phase (95 % CI: −6.2 to −3.2 %) (see Table 2).
After adjustment for patient characteristics (model B),
there was an absolute decrease in mean adherence from
baseline of 1.9 % in the intensive phase (95 % CI: −2.9 to
−0.9 %) and a decrease of 4.2 % in the sustainability phase
(95 % CI: −5.7 to −2.6 %). Adjusting for provider factors
had little impact on these estimates.
Discussion
In our pragmatic trial of practice facilitation, the inter-
vention did not improve adherence to evidence-based
guidelines for cardiovascular disease in primary care
practices. These results contrast with findings from
previously reported facilitation trials [5, 26–28] and
highlight the complexities and challenges of scaling up
research studies into sustainable programs. Suboptimal
intensity of the intervention, a broad focus on multiple
chronic conditions, and measurement challenges are all
factors that may have contributed to the null results.
A meta-analysis conducted of facilitation programs
demonstrated that intensity as measured by number of
facilitation visits was associated with greater effect size
[5]. The IDOCC intervention was designed with the
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intent of having the facilitators meet face-to-face with
practices 13 times (i.e., one visit every 4 weeks) in year 1
(intensive phase) and 4–6 times in year 2 during the sus-
tainability phase [29, 30]. We were unable to attain this
“dose” with our practices, who despite having the best
intentions of engaging and meeting with the facilitators,
were all unable to find the time for this frequency of
meetings. Other facilitation studies have faced similar
issues. For instance, facilitators in a group-randomized
practice facilitation trial conducted in South Texas ini-
tially intended to make monthly facilitation visits over
12 months but due to competing demands within par-
ticipating practices (e.g., EMR implementation, staff
turnover) were only able to make six to seven visits dur-
ing the 1-year study period [31]. The difficulties in
achieving the requisite intensity of visits necessary to fa-
cilitate changes suggest that practice facilitation may not
be as effective in complex, real-world settings. In our
program, no incentives were provided apart from the
opportunity to claim continuing professional develop-
ment credits. Supporting practice change may require
incentives to compensate providers for their time and/or
policies designed to encourage a culture of quality
improvement such as mandatory reporting of quality
metrics and accreditation of primary care practices.
Additionally, financial incentives have been identified as
having a modest positive impact on primary care pro-
cesses associated with quality management of chronic
disease [32].
Improving quality of care delivery for people with mul-
timorbidity is an area that requires more research. Al-
though our study was grounded in the chronic care
model approach with targeted practice level improve-
ment activities across several dimensions within the
model, it failed to improve care delivery. Previous facili-
tation studies primarily focused on single diseases such
as diabetes and asthma [5, 33, 34], whereas our interven-
tion attempted to improve adherence to guidelines for
patients with a broad number of cardiovascular-related
conditions (coronary artery disease, peripheral vascular
disease, stroke/TIA, diabetes, and chronic kidney
disease) and risk factors (hypertension, dyslipidemia,
weight, and smoking). Implementing guidelines for
people with multiple chronic conditions is complex.
While physicians may be able to successfully focus on
single diseases such as diabetes or asthma, improving
adherence across multiple conditions is more challen-
ging. A review of interventions for managing patients
with multimorbidity found that programs targeting
specific areas of concern for the patient (e.g., functional
difficulties) were more effective than broader disease-
oriented programs [35]. Likewise, recent studies (includ-
ing ours) examining the implementation of practice
facilitation programs targeting multiple diseases have
found only modest or insignificant improvements in pa-
tient outcomes [31, 33].
Our analyses identified statistically significant de-
creases in our mean adherence score; however, these
changes are likely the result of our study being overpow-
ered rather than the impact of the program on clinical
behavior. The decreases we detected were smaller than
our pre-specified minimal clinical difference and hence
unlikely to have any clinical significance. We chose to
measure adherence to all indicators using a mean adher-
ence score as we felt it would reflect the reality of man-
aging multiple chronic conditions simultaneously. We
hypothesized that practice facilitation’s focus on practice-
level transformation would lead to changes, which would
positively influence multiple processes of care and could
be captured with a mean score. However, we were unable
to demonstrate this. Measuring impact across multiple
areas is challenging. Our adherence score was an un-
weighted mean in which all indicators were considered
equally important. As a result, it is more difficult to inter-
pret the clinical importance of observed changes: whereas
a decrease of 2–4 % could represent deterioration in one
to two individual indicators if practices improved in some
areas but deteriorated in others, such changes would not
be detectable. For these reasons, future analyses are being
planned of the individual indicators of adherence.
Strengths and limitations
Our study had several strengths, including our popula-
tion approach and implementation across a large geo-
graphic area. We had a large sample size that included a
diverse range of practices. Our stepped wedge design
addressed the need of our funders to eventually offer
this practice improvement program to all participants.
Our low rate of attrition speaks to the feasibility of
establishing ongoing relationships with the practices des-
pite competing demands. Although practices that agreed
to participate may not be representative of all practices
across Eastern Ontario, they represent the kinds of prac-
tices expected to participate in QI initiatives in a real-
world setting. Moreover, in this randomized controlled
trial, internal validity is of primary concern.
Limitations include the use of an index of adherence,
which provides an overall picture of change in adherence
patterns but may hide certain changes that may have
occurred during the intervention. We had also consid-
ered assigning specific weights to each indicator in order
to reflect their relative importance to patient health out-
comes. Unfortunately, there is no empirical evidence for
assigning weighting factors to the indicators in this
study. Although theoretically useful, many authors have
acknowledged the difficulty in effectively determining
meaningful weights, and as such, few researchers use
this approach [36]. Also, due to practical and logistical
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constraints associated with implementing the interven-
tion across a large geographic region, we were unable to
randomize individual practices. As a result of randomiz-
ing at a regional level, there were some imbalances in
the characteristics of participants across the three steps,
as well as differences in the secular trend across steps.
To address these limitations, we adjusted for observed
differences in the analysis and examined models that in-
cluded interactions with each step.
Conclusion
Our findings highlight the complexities of expanding
research evidence into effective, sustainable programs.
Whether practices can commit the time required with-
out policy or incentives is unknown. Further research is
needed to better understand what impact practice facili-
tation can have on eliciting change at this level once im-
plemented more broadly.
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